Infigen, Pharming Group NV, ProBio Inc. deal

PHARM will obtain access to Infigen's IP relating to protein production for an undisclosed sum. The deal supercedes the companies' earlier agreements and releases PHARM from paying future milestones to Infigen (see BioCentury, Oct. 28, 2002). ...